Article
In silico-based vaccine design against Ebola virus glycoprotein
1 Mar 2017
Abstract excerpt
Ebola virus (EBOV) is one of the lethal viruses, causing more than 24 epidemic outbreaks to date. Despite having available molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet for the management and avoidance of EBOV infections in humans. Disclosing this, the present study described an epitope-based peptide vaccine against EBOV, using a combination of B-cell and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
